Chronic Lymphocytic Leukemia Newsfeed

[Ad] Los Angeles Mortgage Protection Insur.

Pays off your mortgage in the event of your death. Get a free quote!

Chronic Lymphocytic Leukemia

Fri, 2 Jan 2009 22:58:33 +0100

Chronic Lymphocytic Leukemia Basics. Comprehensive chronic lymphocytic leukemia cll information for patients, caregivers, physicians and researchers whose interest is chronic lymphocytic leukemia cll.

Bandwidth saved by RSScache.com

Cancer Detection Lab Tests Online

Fri, 2 Jan 2009 22:58:33 +0100

Order cancer detection lab tests online safely and securely. Physicians Order Included. Always Secure. - Read more ...

Bandwidth saved by RSScache.com

Home Test Kit Superstore

Fri, 2 Jan 2009 22:58:33 +0100

Instant Home Tests: Variety Home and Workplace Drug Testing Kits, Tests for Cancer, HIV and AIDS, Fertility Testing Kits and more ...

Bandwidth saved by RSScache.com

Antibody identification in a patient with chronic lymphocytic leukemia: A case study

CLINICAL PRACTICE: HEMATOLOGY ABBREVIATIONS: CLL = chronic lymphocytic leukemia; DAT = direct antiglobulin test; RBC = red blood cells; WAIHA = warm autoimmune hemolytic anemia. INDEX TERMS: antibody identification; chronic lymphocytic leukemia; CLL; hematology; immunohematology; ...

Bandwidth saved by RSScache.com

Current Approach to Diagnosis and Management of Chronic Lymphocytic Leukemia

The care of patients with chronic lymphocytic leukemia has changed dramatically during the past decade. This review summarizes the work-up of lymphocytosis and the current diagnostic criteria and management of CLL. Although clinical staging remains the foundation for ...

Bandwidth saved by RSScache.com

Infection and immunity in chronic lymphocytic leukemia

Patients having chronic lymphocytic leukemia are at increased risk for infectious morbidity and mortality. The predisposition to infections in CLL patients has many components, including both immunodeficiency related to the leukemia itself and the ...

Bandwidth saved by RSScache.com

Alfacell's ONCONASE And R-Amphinase Show Anti-Tumor Activity In Chronic Lymphocytic Leukemia And Acute Myeloblastic ...

Thu, 11 Dec 2008 10:13:35 +0100

Alfacell Corporation (Nasdaq: ACEL) announced that American Society of Hematology (ASH) annual meeting abstracts in Blood (2008 112: Abstract 4205 and 2008 112: Abstract 4010) report that ONCONASE (ranpirnase) and R-Amphinase (R-Amph) show anti-tumor activity in chronic lymphocytic leukemia (CLL) and

Bandwidth saved by RSScache.com

Genta To Appeal FDA Decision On New Drug Application For Genasense In Patients With Chronic Lymphocytic Leukemia

Mon, 15 Dec 2008 13:12:03 +0100

Genta Incorporated (OTCBB: GNTA.OB) announced that the Company has filed an appeal of the recent negative decision by the Food and Drug Administration's (FDA) Office of Oncology Drug Products (OODP) regarding the Company's New Drug Application (NDA) for Genta's lead oncology product, Genasense� (oblimersen sodium) Injection.

Bandwidth saved by RSScache.com

Dismissed Leukemia Drug Helps Chronic Lymphocytic Leukemia Patients, Studies Show

Tue, 9 Dec 2008 13:17:32 +0100

A drug once dismissed as ineffective in patients with chronic lymphocytic leukemia has shown promising results in two phase I and II clinical trials, according to new research.

Bandwidth saved by RSScache.com

Lenalidomide safe for elderly patients with chronic lymphocytic leukemia (News-Medical-Net)

Tue, 9 Dec 2008 04:48:26 +0100

The oral medication lenalidomide is safe and well-tolerated for elderly patients with chronic lymphocytic leukemia, a group without a well-defined frontline therapy for their disease, researchers from The University of Texas M. D. Anderson Cancer Center reported today at the 50th annual meeting of the American Society of Hematology.

Bandwidth saved by RSScache.com

[Ad] 1 flat stomach rule: obey

I cut out 2 lbs of stomach fat per week by obeying this 1 old rule

Rituxan in combination with chemo improves survival in chronic lymphocytic leukemia (News-Medical-Net)

Mon, 8 Dec 2008 20:19:24 +0100

Genentech, Inc. and Biogen Idec have announced that two global Phase III studies in chronic lymphocytic leukemia (CLL), CLL8 and REACH, showed Rituxan (rituximab) plus chemotherapy significantly increased the time patients lived without their disease advancing, as defined by the primary endpoint of progression-free survival (PFS), when compared to chemotherapy alone.

Bandwidth saved by RSScache.com

Dismissed leukemia drug flavopiridol helps chronic lymphocytic leukemia patients (News-Medical-Net)

Mon, 8 Dec 2008 20:48:14 +0100

A drug once dismissed as ineffective in patients with chronic lymphocytic leukemia (CLL) has shown promising results in two phase I and II clinical trials, according to researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Bandwidth saved by RSScache.com

Genta to Appeal FDA Decision on New Drug Application for Genasense� in Patients with Chronic Lymphocytic Leukemia

Thu, 11 Dec 2008 20:57:04 +0100

Genta Incorporated (OTCBB: GNTA.OB) announced that the Company has filed an appeal of the recent negative decision by the Food and Drug Administration?s (FDA) Office of Oncology Drug Products (OODP) regarding the Company?s New Drug Application (NDA) for Genta?s lead oncology product, Genasense � (oblimersen sodium) Injection. The NDA proposed the use of Genasense in combination with ...

Bandwidth saved by RSScache.com

Infection and immunity in chronic lymphocytic leukemia

Bandwidth saved by RSScache.com